PANAFCORT prednisone 25 mg tablet bottle

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

prednisone, Quantity: 25 mg

Disponível em:

Aspen Pharmacare Australia Pty Ltd

Forma farmacêutica:

Tablet, uncoated

Composição:

Excipient Ingredients: povidone; maize starch; crospovidone; lactose monohydrate; magnesium stearate; macrogol 6000

Via de administração:

Oral

Unidades em pacote:

30, bulk

Classe:

Medicine Registered

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Wherever corticosteroid therapy is indicated such as: pemphigus vulgaris, allergic dermatitis, eczema, exfoliative dermatitis, dermatitis herpetiformis, dermatitis medicamentosa, erythema multiforme; disseminated lupus erythematosus, dermatomyositis, polyarteritis nodosa; severe bronchial asthma and status asthmaticus, emphysema, pulmonary fibrosis; adrenal hyperplasia (adrenogenital syndrome); idiopathic thrombocytopenic purpura, acquired haemolytic anaemia, acute leukaemia; nephrotic syndrome; iridochoroiditis; ulcerative colitis; rheumatoid arthritis; ankylosing spondylitis, rheumatic fever, gout, periarthritis of the shoulder

Resumo do produto:

Visual Identification: Round, biconvex, white, scored tablet debossed with "PN/25" on one side and plain on the other.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Status de autorização:

Registered

Data de autorização:

1991-10-21

Folheto informativo - Bula

PANAFCORT
1
PANAFCORT
_prednisone _
CONSUMER MEDICINE INFORMATION (CMI)
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about PANAFCORT. It
does not contain all the information
that is known about PANAFCORT.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking
PANAFCORT against the benefits
they expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT PANAFCORT IS
USED FOR
PANAFCORT contains prednisone
as the active ingredient. Prednisone
belongs to a group of medicines
called corticosteroids which are a
synthetic version of a naturally
occurring body hormone called
cortisol.
PANAFCORT is used in the
treatment of many different
conditions. Some of these conditions
include: severe allergies, severe or
chronic asthma, skin problems,
arthritis, inflammatory diseases of
the bowel, cancer and "auto-immune"
diseases.
It is also used to prevent or reduce
the symptoms of inflammation (such
as swelling, redness, pain, tenderness
or itching) in any part of the body.
These symptoms can occur in
response to injury or can be caused
by many different conditions.
PANAFCORT works by entering
inflammatory cells and blocking the
inflammatory reaction. It is only
able to prevent or reduce symptoms
of your condition, it does not cure it.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY
PANAFCORT HAS BEEN PRESCRIBED
FOR YOU.
Your doctor may have prescribed it
for another purpose.
This medicine is only available with
a doctor's prescription.
There is no evidence that it is
addictive.
BEFORE YOU TAKE IT
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE PANAFCORT IF YOU
HAVE EVER HAD AN ALLERGIC REACTION
TO:

prednisone or prednisolone

any of the tablet ingredients
listed at the end of this leaflet.
Symptoms of an allergic reaction
may include shortness of breath,
wheezing or difficulty in b

Características técnicas

1
AUSTRALIAN PRODUCT INFORMATION
PANAFCORT (PREDNISONE) TABLETS
1
NAME OF THE MEDICINE
Prednisone.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
PANAFCORT tablets contain either 1 mg, 5 mg or 25 mg of the active
prednisone.
List of excipients with known effects: lactose monohydrate. For the
full list of excipients, see
Section 6.1 List of excipients.
3
PHARMACEUTICAL FORM
1 mg: Round, biconvex, white scored tablet with ‘PN/1’ on one side
and plain on the other.
5 mg: Round, biconvex, white scored tablet debossed with ‘PN/5’ on
one side and plain on
the other.
25 mg: Round, biconvex, white scored tablet debossed with ‘PN/25’
on one side and plain on
the other.
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
Wherever corticosteroid therapy is indicated such as: pemphigus
vulgaris, allergic dermatitis,
eczema, exfoliative dermatitis, dermatitis herpetiformis, dermatitis
medicamentosa, erythema
multiforme; disseminated lupus erythematosus, dermatomyositis,
polyarteritis nodosa;
severe bronchial asthma and status asthmaticus, emphysema, pulmonary
fibrosis; adrenal
hyperplasia (adrenogenital syndrome); idiopathic thrombocytopenic
purpura, acquired
haemolytic anaemia, acute leukaemia; nephrotic syndrome;
iridochoroiditis; ulcerative colitis;
rheumatoid arthritis; ankylosing spondylitis, rheumatic fever, gout,
periarthritis of the
shoulder.
4.2
D
OSE AND METHOD OF ADMINISTRATION
The severity, prognosis, expected duration of the disease, and the
patient's reaction to
medication are primary factors in determining dosage.
Despite the 1 mg tablet being scored, it should not be broken.
Adults: The initial adult dosage may range from 20 to 40 mg daily, but
can be 60 to 80 mg
daily if necessary, depending on the disease being treated.
Maintenance dosage: Usually 5
to 20 mg daily. In long term therapy the ideal dosage should not be
greater than 40 mg per
2
day so as to minimise side-effects. It is usually administered in 2-4
divided doses or as a
single daily dose after breakfast or on alternate days.
Alternate-Day